Terms: = Bone cancer AND uPA AND Treatment
38 results:
1. Morin inhibits osteosarcoma migration and invasion by suppressing urokinase plasminogen activator through a signal transducer and an activator of transcription 3.
Yang JS; Chou CH; Hsieh YH; Lu PW; Lin YC; Yang SF; Lu KH
Environ Toxicol; 2024 Apr; 39(4):2024-2031. PubMed ID: 38093596
[TBL] [Abstract] [Full Text] [Related]
2. Bisdemethoxycurcumin suppresses human osteosarcoma U‑2 OS cell migration and invasion via affecting the PI3K/Akt/NF‑κB, PI3K/Akt/GSK3β and MAPK signaling pathways
Ma YS; Peng SF; Wu RS; Chueh FS; Huang WW; Chen PY; Kuo CL; Huang AC; Liao CL; Hsia TC
Oncol Rep; 2022 Dec; 48(6):. PubMed ID: 36222295
[TBL] [Abstract] [Full Text] [Related]
3. Dihydromyricetin suppresses cell metastasis in human osteosarcoma through SP-1- and NF-κB-modulated urokinase plasminogen activator inhibition.
Chou CH; Lu KH; Yang JS; Hsieh YH; Lin CW; Yang SF
Phytomedicine; 2021 Sep; 90():153642. PubMed ID: 34265701
[TBL] [Abstract] [Full Text] [Related]
4. Transforming growth factor-β-regulated fractalkine as a marker of erosive bone invasion in oral squamous cell carcinoma.
Son SH; Park J; Jung MJ; Lee SK; Kim H; Kim KR; Park KK; Chung WY
Eur J Oral Sci; 2021 Feb; 129(1):e12750. PubMed ID: 33503283
[TBL] [Abstract] [Full Text] [Related]
5. Curcumin Analogue L48H37 Suppresses Human Osteosarcoma U2OS and MG-63 Cells' Migration and Invasion in Culture by Inhibition of upa via the JAK/STAT Signaling Pathway.
Lu KH; Wu HH; Lin RC; Lin YC; Lu PW; Yang SF; Yang JS
Molecules; 2020 Dec; 26(1):. PubMed ID: 33374783
[TBL] [Abstract] [Full Text] [Related]
6. Inhibitory Effects of a Reengineered Anthrax Toxin on Canine and Human Osteosarcoma Cells.
Mackowiak da Fonseca J; Mackowiak da Fonseca II; Nagamine MK; Massoco CO; Nishiya AT; Ward JM; Liu S; Leppla SH; Bugge TH; Dagli MLZ
Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 32987941
[TBL] [Abstract] [Full Text] [Related]
7. Fisetin Suppresses Human Osteosarcoma U-2 OS Cell Migration and Invasion
Chen JK; Peng SF; Lai KC; Liu HC; Huang YP; Lin CC; Huang AC; Chueh FS; Chung JG
In Vivo; 2019; 33(3):801-810. PubMed ID: 31028200
[TBL] [Abstract] [Full Text] [Related]
8. Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health.
Neri M; Pilloni M; Paoletti AM; Melis GB; Piras B; Ajossa S; Marotto MF; Corda V; Ronchi A; Giancane E; Vallerino V; Saba A; Zedda P; Orani MP; Cappai R; Coghe F; Mais V
Gynecol Endocrinol; 2019 Sep; 35(9):756-761. PubMed ID: 30822182
[TBL] [Abstract] [Full Text] [Related]
9. Inflammation-driven colon neoplasmatogenesis in upa-deficient mice is associated with an increased expression of Runx transcriptional regulators.
Afaloniati H; Karagiannis GS; Hardas A; Poutahidis T; Angelopoulou K
Exp Cell Res; 2017 Dec; 361(2):257-264. PubMed ID: 29107070
[TBL] [Abstract] [Full Text] [Related]
10. u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression.
Ciavarella S; Laurenzana A; De Summa S; Pilato B; Chillà A; Lacalamita R; Minoia C; Margheri F; Iacobazzi A; Rana A; Merchionne F; Fibbi G; Del Rosso M; Guarini A; Tommasi S; Serratì S
BMC Cancer; 2017 Mar; 17(1):215. PubMed ID: 28340565
[TBL] [Abstract] [Full Text] [Related]
11. Suppression of IL-8-Src signalling axis by 17β-estradiol inhibits human mesenchymal stem cells-mediated gastric cancer invasion.
Liu CJ; Kuo FC; Wang CL; Kuo CH; Wang SS; Chen CY; Huang YB; Cheng KH; Yokoyama KK; Chen CL; Lu CY; Wu DC
J Cell Mol Med; 2016 May; 20(5):962-72. PubMed ID: 26945908
[TBL] [Abstract] [Full Text] [Related]
12. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
[TBL] [Abstract] [Full Text] [Related]
13. Deguelin inhibits the migration and invasion of U-2 OS human osteosarcoma cells via the inhibition of matrix metalloproteinase-2/-9 in vitro.
Shang HS; Chang JB; Lin JH; Lin JP; Hsu SC; Liu CM; Liu JY; Wu PP; Lu HF; Au MK; Chung JG
Molecules; 2014 Oct; 19(10):16588-608. PubMed ID: 25322282
[TBL] [Abstract] [Full Text] [Related]
14. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in pediatric human sarcoma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2013 Oct; 43(4):1027-35. PubMed ID: 23900236
[TBL] [Abstract] [Full Text] [Related]
15. Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells.
Chen HJ; Lin CM; Lee CY; Shih NC; Peng SF; Tsuzuki M; Amagaya S; Huang WW; Yang JS
Oncol Rep; 2013 Aug; 30(2):925-32. PubMed ID: 23708932
[TBL] [Abstract] [Full Text] [Related]
16. [Effect of bisphosphonates on anticancer activity in prostate cancer cells].
Iguchi K
Yakugaku Zasshi; 2012; 132(9):1025-30. PubMed ID: 23023419
[TBL] [Abstract] [Full Text] [Related]
17. Epigenetic upregulation of urokinase plasminogen activator promotes the tropism of mesenchymal stem cells for tumor cells.
Pulukuri SM; Gorantla B; Dasari VR; Gondi CS; Rao JS
Mol Cancer Res; 2010 Aug; 8(8):1074-83. PubMed ID: 20663859
[TBL] [Abstract] [Full Text] [Related]
18. Identification of a novel biomarker signature associated with risk for bone metastasis in patients with renal cell carcinoma.
Paule B; Deslandes E; Le Mouel SP; Bastien L; Podgorniak MP; Allory Y; de la Taille A; Menashi S; Calvo F; Mourah S
Int J Biol Markers; 2010; 25(2):112-5. PubMed ID: 20544684
[TBL] [Abstract] [Full Text] [Related]
19. Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression.
Wu KJ; Zeng J; Zhu GD; Zhang LL; Zhang D; Li L; Fan JH; Wang XY; He DL
Acta Pharmacol Sin; 2009 Aug; 30(8):1162-8. PubMed ID: 19578386
[TBL] [Abstract] [Full Text] [Related]
20. upaR mediates anticancer activity of PEDF.
Dass CR; Choong PF
Cancer Biol Ther; 2008 Aug; 7(8):1262-70. PubMed ID: 18487955
[TBL] [Abstract] [Full Text] [Related]
[Next]
